Correlation Between Driver Gene Abnormalities and Clinicopathological Characteristics and Disease Prognosis in Lymphoma
Eligibility
Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria:
1. Diagnosed as lymphoma (according to WHO 2017 classification criteria)
2. Life expectancy no less than 3 months
3. Agreeing to sign the written informed consents
Exclusion Criteria:
1. Other malignant tumor history or active malignant tumor need be treated
2. Researchers determine unsuited to participate in this trial
Primary outcome measure(s)
Incidence of driver gene abnormalities — from the day of the first patient was included to the date of the end of this trial, assessed up to 36 months the incidence of driver gene abnormalities by fixed gene testing technology
Trial sites (1)
Facility
City
Region
Status
Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZhou university
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.